SCHEMBL23997789

SCHEMBL23997789

C/C=C/C(=O)N1CCC(C)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.47
▸ HPGD P15428 5/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ LMNA P02545 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ JAK3 P52333 4/20 0.38
▸ MAOB P27338 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ POLB P06746 1/20 0.37
▸ ACHE P22303 1/20 0.36
▸ JAK1 P23458 1/20 0.36
▸ DPP4 P27487 1/20 0.35
▸ DPP8 Q6V1X1 1/20 0.35
▸ DPP7 Q9UHL4 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRB2 P47870 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18331786 0.89 HPGD (0.58) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL17928596 0.89 HPGD (0.58) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL1687961 0.89 HPGD (0.58) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL25366205 0.89 HPGD (0.58) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL25365606 0.88 HPGD (0.50) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL24089737 0.88 HPGD (0.50) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL25366713 0.87 HPGD (0.54) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL25365817 0.81 HPGD (0.46) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL25367205 0.80 ALDH1A1 (0.50) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL10285827 0.78 LMNA (0.44) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4006035-B1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER NEUPHARMA INC (US) 2023-11-22 — — EP disclosed
EP-3497087-B1 PYRROLO[1,2-C]PYRIMIDINE, IMIDAZO[1,5-C]PYRIMIDINE, QUINAZOLINE, PURINE AND IMIDAZO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER NEUPHARMA INC (US) 2021-11-10 — — EP disclosed
Send feedback